3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Cyclophosphamide
27
fludarabine phosphate
19
Whole-Body Irradiation
18
Peripheral Blood Stem Cell Transplantation
18
Etoposide
17
Rituximab
15
Brentuximab Vedotin
15
Mycophenolic Acid
14
Tacrolimus
13
Doxorubicin
12
Vincristine
11
Prednisone
11
Methotrexate
11
Busulfan
11
Melphalan
9
Antilymphocyte Serum
9
Cyclosporine
8
Filgrastim
6
Carboplatin
6
Sirolimus
5
Radiotherapy
5
Lenalidomide
5
Gene Expression Profiling
5
Cytarabine
5
merphos
4
Vorinostat
4
Immunohistochemistry
4
Ifosfamide
4
Gemcitabine
4
Flow Cytometry
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large-Cell, Anaplastic
×
cemiplimab
×
Clear all
No trials found.